More Adherium Ltd. news
Adherium Ltd.ASX: ADR

Adherium Smartinhaler used in Global Mild-Asthma Studies

May 21, 2018 at 12:18 AM EDT · Issued by Adherium Ltd.

Filed with ASX · May 21, 2018 at 12:18 AM EDT

On 6ix: 6ix.com/news/adherium-smartinhaler-used-in-global-mild-asthma-studies

Adherium Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Adherium Ltd. on 6ix

Story so far

  • NICE reports on Adherium Smartinhaler for asthma managementJan 12, 2017
  • Adherium Smartinhaler dramatically improves outcomesNov 17, 2016
  • Adherium Smartinhaler in AstraZeneca COPD StudyJun 14, 2016

Earlier from Adherium

  • Adherium launches new global brand HailieMay 16, 2018
  • Adherium Announces Program with Vitalus HealthMay 1, 2018
  • Adherium receives US FDA 510k OTC clearanceMar 27, 2018
  • Asthma Adherence Management FindingsMar 7, 2018
  • Adherium Investor Conference CallFeb 6, 2018

Later from Adherium

  • Adherium Program with Connecticut Childrens Medical CenterJul 10, 2018
  • Adherium Receives Additional US FDA 510(k) ClearanceJul 26, 2018
  • Adherium Launches Hailie™ Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD ManagementAug 13, 2018
  • Adherium and Vitalus Health Launch Commercial ProgramAug 23, 2018
  • Adherium Announces Q1 Fiscal Year 2019 Investor Conference CallOct 25, 2018
All Adherium news releases↗

Follow Adherium into a list and get an email when it puts out news.

Follow Adherium
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer